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Nitric Oxide is Protective Against Mercury Induced 
Depression 
tic criteria for dysthymic disorder are: low mood during 
the day or most times of the day for at least one year in 
adults or two years in children, with at least two of fol-
lowing items: decrease or increase of appetite, insom-
nia or hypersomnia, loss of energy, low self-confidence, 
concentration and decision making disorders, feel of 
sadness and hopelessness (Freidman, 1995).
                 1. Introduction
egard to DSM-IV depression has three 
subtypes, including: Dysthymia, chronic 
major depression, and major depression 
superimposed with dysthymia (American 
psychiatric association: Diagnostic and 
statistical manual of mental disorders, 2005). Diagnos-
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Accepted: 25 June 2010 Introduction: Mercury is the second most metal pollutant in the world and has the 
potential to induce many pathologic conditions, especially in nervous system, such 
as depression. Here we tried to find out if nitric oxide has any possible role in the 
pathophysiology of depression induced by this metal.  Although the role of nitric 
oxide has been shown in mood control, here we use specific doses of nitric oxide 
inducer and/or inhibitors which had no effect on normal rats. 
Methods: 120 male wistar rats weighting 200-250 gram were divided into two main 
groups: control and methyl mercury(MM) treated.  Each main group was divided 
into four different sub-goups: Saline, L-Arginine, L-Name or 7-nitroindazole 
(7-NI) respectively. The duration of taking MM or saline was daily for 15 days for 
both. After the 15th injection a forced swimming test was done. This test shows 
behavioral immobility (BI) or latency of attempt to escape (LAE), as a depression 
indicator.
Results: Our study showed that low dose L-arginine is protective against MM 
induced depression as it could turn behavioral immobility (BI) to normal levels 
in groups taking  MM plus L-Arginine, while in group taking just MM, BI was 
much longer showing the intensity of depression. L-Name and 7-NI did aggravated 
depression in MM groups but not control ones, on the other hand just in the case of 
7-NI the result was significant.
Discussion: Our results showed 1) MM could induce depression in rat 2) L-Arginine 
could improve depression to normal situation in MM group, while in control group 
has no effec 3) 7-NI, a selective nNOS inhibitor can aggravate mental depression 
in intoxicated rats. These results showed the important role of nNOS in protection 
against MM induced depression.
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Depression is among the 10 most prevalent diseases in the 
world and the most prevalent mental disorder too. 25 percent 
of people will experience it at least once during their life. 
It has been cited as the first reason for employee absences 
around 2010, too. It is twofold more prevalent in women 
(American Psychiatric Association: Diagnostic and statisti-
cal manual of mental disorders, 2005). Depression can lead 
to concentration disability and therefore, problems in social 
and interpersonal relationships. In many cases it may cause 
family and job loss or even suicide (Freidman, 1995).
Genetic factors may prone people to evolve mental de-
pression. Prevalence of depression is 57 percent in identical 
twins. Chromosome 6 genes are among the most suspicious 
ones. Polymorphisms of these genes predispose people 
to this condition and make them more prone to develop 
depression. It means environmental factors such as social 
and personal conflicts may switch on depression in geneti-
cally susceptible individuals (Swivan, 1981).  Researchers 
in Rochester University have suggested  that screening for 
depression-prone subjects may have a gene linkage pos-
sibly in chromosome 6 (Swivan, 1981). Although stress re-
sponses are physiologically regulated and occur normally in 
everyday life, if they become persistent and severe depres-
sion can result (Kessler et al., 1994). Stress hormones try to 
overcome the situation following stress, but in continuous, 
uncontrolled stress they have some deleterious effects on 
the brain, especially on the hippocampus (Kroenke, 2003; 
Schneider, 1958; Wu, Parkerson, & Doraiswamy, 2002). 
Environmental pollutants also may cause depression (Ven-
tura et al., 2004).  Mercury is the most prevalent “metal 
pollutant” in the world. Two different types of mercury are 
organic and inorganic ones. The main source of mercury 
is from inside the earth. Volcanoes, earthquakes, and deep 
wells (such as petroleum pumps), can cause mercury to 
seep to the surface of the earth, at any strata.  Planktons in 
the water digest the mercury and change inorganic mer-
cury to more toxic organic types.   Fishes will then eat the 
plankton and the next ring of the chain will be humans. 
This is one of the most common ways to cause mercury 
intoxication; two other routes  are  through dental fillings 
with amalgam and vaccinations (Crinnion, 2000). How-
ever mercury intoxication in human makes different organ 
dysfunctions, of which the most prominent affected, is ner-
vous system. Ataxia, dysartheria, and convulsions can be 
induced by mercury intoxication(Fukuda, Ushijima, Kita-
no, Sakamoto, & Futatsuka, 1999; Kauppinen, Komulain-
en, & H, 1989). However depression is also among the first 
signs and symptoms of this process (Ventura et al., 2004) 
(8). There is no clinical differentiating factor between other 
types of depression and mercury induced ones (Chuu, Liu, 
& Lin-Shiau, 2001; Kauppinen et al., 1989).
Previous studies have shown that nitric oxide (N.O.), 
as a multi-potent agent, has an important role in the 
pathophysiology of depression, which comes from its 
specific properties (Marek & Duman, 2002). However 
it should be considered that N.O. based on its concentra-
tion and location can act as both as an oxidant or as an 
antioxidant agent (Yamashita, 1997) .
2. Methods
120 male wistar rats, weighting 200-250 gram, with 
free access to water and standard food, living in 12 
hour dark/cycle entered the study.  Efforts were made 
to minimize animal suffering. Rats were divided to two 
main groups (Table 1), case (n=60) and control (n=60). 
Methyl mercury (M.M.) intoxication was induced in 
case groups orally (gavage). They were fed M.M. (5 
mg/kg, daily) for 14 days with a feeding syringe. The 
control group took saline with the same plan. Each main 
group divided into four subgroups, taking one of the 
following agents for 14 days of treatment, including: 7 
Nitro-indazole, a neuronal specific NOS inhibitor (5mg/
kg, subcutaneous, twice a week), or L-Name, a nonspe-
cific NOS inhibitor (10 mg/kg, IP, twice a week), or L-
Arginine, a N.O. donor agent (50 mg/kg, IP, every other 
day), or saline (1ml/kg, IP, twice a week). 
It has been shown that M.M. intoxication with this 
dose may affect normal gait after 17 days after intoxi-
cation (Yamashita, 1997). However the behavioral test 
(FST) was started in the 15th day after the first M.M. 
Administration.  The rats were checked for any move-
ment abnormality before each behavioral test session. 
Abnormal moving rats didn’t enter the test phase.
Modified Forced Water Swim Test
Modified forced water swim test is a version of clas-
sic “forced water swim test” The forced water swim 
test was first introduced by Porsolt and his colleagues 
(Porsolt, Le Pichon, & Jalfre, 1977). This behavioral 
test helps to detect depression, or better to say its sever-
   Table 1. shows groups of the study (n: 120)
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ity of course, and evaluation of  antidepressant drugs 
in rodents (Mendes-da-Silva et al., 2002; Porsolt et. al., 
1977). The device used in this test is a container with 
42 cm height, 105 cm in diameter, made of steel and black 
colored inside. The container was filled with water (with a 
temperature of 25 °C) up to 18 cm height (Mendes-da-Sil-
va et al., 2002). After each trial the container was cleaned 
and washed. The test makes an inescapable situation for 
the experimental animals. As a result there is a spectrum in 
behavioral response from hyperactivity and try to escape 
risky situation (which is named “latency of attempt to es-
cape”  or  “LAE”) to inactivity, no motivation for escape 
and just prevention of death by putting one’s nose up on 
the water surface (this reaction is named “behavioral im-
mobility “  or  “BI”). The Longer time periods of BI shows 
the severity of depression based on length (Mendes-da-
Silva et al., 2002; Porsolt, 2000).  The time that it takes 
to escape from situation, swimming or climbing, is named 
“latency of the attempts to escape” or “LAE”. It shows that 
the animal still has the motivation to stay alive, has enough 
energy and tendency to get rid of lethal situations (Mend-
es-da-Silva et al., 2002). If the response while flooded in 
water was staying immobile just to ventilate with no at-
tempt to escape, it is considered as a marker of despair or 
depression; it is named behavioral immobility or “BI.”  All 
groups had a pretest trial session and a test the day after. In 
the pretest trial animals were put in the center of the con-
tainer for fifteen minutes (Mendes-da-Silva et al., 2002). 
The day after, in the test session, each rat had the same 
experience but just for five minutes. After each trial rats 
were removed from water and dried gently with a cotton 
towel (Mendes-da-Silva et al., 2002).
3. Results
 The mean behavioral immobility (BI) of eight differ-
ent groups were compared using one-way ANOVA test 
and Tukey as post-hoc, for revealing the differences be-
tween groups. The results (Figure 1) showed that there 
was a significant difference in behavioral immobility 
score between studied groups (p< 0.05).
Effect of methyl mercury on behavioral immobility
Tukey post-hoc- analysis showed that BI is increased 
in the methyl mercury group (methyl mercury + saline) 
compared to vehicle treated group (p< 0.05).
Effect of nitric oxide modulators on behavioral immobility 
The results indicated that none of the 7-nitroindazole, 
L-Name, or L-Arginine groups had significant effect on 
BI score in vehicle treated rats (p> 0.05). But in M.M. 
treated groups results were different.
Groups that have received 7-nitroindazole with 
M.M. showed more BI compared to M.M. plus saline 
(p<0.05). L-Name also increased BI score but it was 
not significant (p>0.05). On the other hand L-Arginine 
decreased BI score in M.M. treated rats (p<0.05) to the 
level of control groups.
4. Discussion
In parallel or even exceeding to technical, industrial and 
medical developments, prevalence of mood and related 
behavioral disorders such as depression, anxiety, violence, 
alcoholism and aggression are also growing up (Siblerud, 
1994). Recent studies have shown that environmental 
and food pollutions with heavy metals and certain medi-
cal procedures such as vaccination and dental filling with 
amalgam may have a role in this phenomenon. Mercury 
has attracted researcher attention in this filed and some 
epidemiologic studies have shown the relation of depres-
sion with mercury (Crinnion, 2000; Windham, 2010). Al-
though the effects of mercury as a neurotoxic heavy metal 
well studied in cerebellar degeneration and related ataxia 
(Fukuda et. al., 1999; Kauppinen et al., 1989; Yamashita, 
1997) its possible role in the etiology of depression is less 
known. The etiology and involved neural systems in de-
pression is not clearly identified. However, it has been 
Figure 1.
-
kg, by gavage,for 15 days) or vehicle (saline). Each group 
-
cant compare to Methyl Mercury+saline group. ** p<0.05, 
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shown that inflammatory process may have a role in the 
pathogenesis of depression; especially in some animal 
models of depression there was a relationship between 
inflammatory process, hippocampus damage and depres-
sive behavior (Holsboer, 2001; Leonard, 2007; Marek & 
Duman, 2002).
Results of the study show that chronic intoxication 
with methyl mercury increases behavioral immobil-
ity in modified forced swim test in rats. It means that 
chronic methyl mercury intoxication can induce depres-
sion.  Another finding of the study is that nitric oxide 
may have a role in this process.
It has been shown that mercury intoxication can dam-
age the nervous system with different mechanisms, such 
as release of free radicals, inflammation and interference 
with neurotransmitters release and uptake (Albrecht & 
Matyja, 1996; Bemis & Seegal, 2000; Brookes, 1992; 
Hobson & Rajanna, 1985; Hussain, 1997; Kim & Satoh, 
2000; Mahboob, Shireen, Atkinson, & Khan, 2001).
On the other side 7-NI, L-Name or L-Arginine, with the 
dosage used in our study, had no considerable effect on 
BI in control groups. However, In M.M. treated groups 
that took NOS modulator agents, the results were differ-
ent. 7-NI in M.M. group increased “BI” indicating sever-
ity of depression, and possibly more oxidative damage to 
brain. 7-NI is a nNOS (neuronal nitric oxide synthase) is 
a selective neural NOS inhibitor; it could be suggested 
that, after 7-NI  administration, reduction of brain N.O. 
concentrations and its protection against oxidative stress, 
in result, yield an inflammatory reaction in brain. In such 
a condition clinical mental depression starts.
 On the other hand L-Name in M.M. treated groups 
could increase but these changes would not be meaning-
ful. Probably it means L-Name as a nonspecific NOS 
inhibitor cannot block nNOS enough to make consid-
erable decrease in N.O. concentration; so there was an 
increased “BI,” but again not significant. On the other 
hand it could be suggested that, in oxidative conditions 
in the brain, L- Name cannot stop antioxidant concen-
trations of N.O., so there will be enough active enzymes 
to inhibit the  oxidative  stress process.
And finally we could show that L-Arginine (a N.O. 
donor) could prevent mental depression in M.M. intox-
icated rat (normal “BI” level). However, it should be 
considered that, this dose of L-Arginine had no obvious 
effects on the normal behavior of rat.  It can be conclud-
ed that as M.M. makes oxidative stress, an acceptable 
modest increase in N.O. concentration can be helpful in 
protecting the brain from injury. 
We can suggest that M.M. induced mental depression 
could be prevented by low doses of nitric oxide, and 
can worsen completely much more severely after nNOS 
inhibition, by 7-NI and to some extent L-Name, which 
is not a specific NOS inhibitor.
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